IRIS
ZAPPAVIGNA, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.242
NA - Nord America 2.035
AS - Asia 217
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 4
OC - Oceania 3
AF - Africa 1
Totale 4.506
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.027
IE - Irlanda 795
IT - Italia 476
GB - Regno Unito 226
UA - Ucraina 225
DE - Germania 146
FR - Francia 104
SE - Svezia 86
CN - Cina 84
GR - Grecia 69
FI - Finlandia 67
VN - Vietnam 54
TR - Turchia 41
BE - Belgio 19
KR - Corea 9
NL - Olanda 9
CA - Canada 8
IN - India 7
IR - Iran 7
PL - Polonia 7
PK - Pakistan 6
JP - Giappone 5
BR - Brasile 4
EU - Europa 4
AU - Australia 3
RU - Federazione Russa 3
SG - Singapore 3
CZ - Repubblica Ceca 2
DK - Danimarca 2
BG - Bulgaria 1
CH - Svizzera 1
EE - Estonia 1
ES - Italia 1
KE - Kenya 1
MD - Moldavia 1
RS - Serbia 1
SY - Repubblica araba siriana 1
Totale 4.506
Salva come PNG Salva come JPEG
Città #
Dublin 795
Chandler 517
Jacksonville 363
Caserta 98
Princeton 96
Roxbury 83
New York 79
Medford 73
Bremen 58
Ann Arbor 54
Dong Ket 54
Naples 53
Des Moines 35
Boardman 33
Cambridge 33
Wilmington 33
Napoli 31
Beijing 29
Woodbridge 25
Mountain View 24
San Mateo 22
Ashburn 21
Brussels 18
Milan 13
Campodarsego 11
Helsinki 10
Rome 10
San Nicola la Strada 10
Aversa 9
San Felice A Cancello 9
Jinan 8
Elora 7
Houston 7
Nanjing 7
Redwood City 7
Düsseldorf 6
Seregno 6
Auburn Hills 5
Lissone 5
Ningbo 5
Norwalk 5
Scafati 5
Berlin 4
Changsha 4
Lappeenranta 4
Los Angeles 4
Tianjin 4
Torre Annunziata 4
Amsterdam 3
Bologna 3
Frankfurt am Main 3
Groningen 3
Guangzhou 3
Hebei 3
Munich 3
Panettieri 3
San Giorgio a Cremano 3
Scandiano 3
Seattle 3
Shenyang 3
Siena 3
Taiyuan 3
Amantea 2
Brno 2
Cagliari 2
Capannori 2
Cosenza 2
Dearborn 2
Delhi 2
Fairfield 2
Florence 2
Frattaminore 2
Freigericht 2
Genova 2
Gragnano 2
Haikou 2
Hyderabad 2
Kunming 2
Nanchang 2
Parma 2
Pomigliano d'Arco 2
Portici 2
Salerno 2
Sassari 2
Sydney 2
Taunsa 2
Terzigno 2
Tricase 2
Udine 2
Vertova 2
Washington 2
Athens 1
Bascape 1
Belo Horizonte 1
Bergamo 1
Bocale 1
Bovisio Masciago 1
Boydton 1
Capri 1
Casoria 1
Totale 2.905
Salva come PNG Salva come JPEG
Nome #
Espressione del recettore dell’urotensina-II nell’adenocarcinoma del colon umano: studi in vitro ed in vivo. 100
Valutazione in vitro degli effetti cardiotossici da 5-Fluorouracile per la prevenzione dei danni cardiovascolari negli operatori sanitari professionalmente esposti. [Evaluation in vitro of the cardiotoxic effects of 5-fluorouracil for the prevention of cardiovascular damage in health workers occupationally exposed]. 97
NANOPARTICELLE FUNZIONALIZZATE CON TRANSFERRINA ED INCAPSULANTI ACIDO ZOLEDRONICO DETERMINANO INIBIZIONE DELLA CRESCITA DEL GLIOBLASTOMA INTRACRANICO IN VIVO 87
MicroRNA-423-5p promotes autophagy in cancer cells and is increased in serum from hepatocarcinoma patients treated with sorafenib 85
The 1,4 benzoquinone-featured 5-lipoxygenase inhibitor RF-Id induces apoptotic death through downregulation of IAPs in human glioblastoma cells 84
Effect of restriction vegan diet's on muscle mass, oxidative status, and myocytes differentiation: A pilot study 79
Dicrocoelium dendriticum induces autophagic vacuoles accumulation in human hepatocarcinoma cells 78
Stealth liposomes encapsulating zoledronic acid: a new opportunity to treat neuropathic pain. 72
5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress. 70
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment 70
Mitochondria as playmakers of apoptosis, autophagy and senescence 68
Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells 67
Emerging strategies to strengthen the anti-tumour activity of type I IFNs: overcoming survival pathways 65
Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC. 65
The methyl donor S-adenosylmethionine potentiates doxorubicin effects on apoptosis of hormone-dependent breast cancer cell lines. 64
Hydrogen sulfide reduces cell adhesion and relevant inflammatory triggering by preventing ADAM17-dependent TNF-α activation 63
Urotensin-II receptor expression in human colon adenocarcinoma: in vitro and in vivo studies. 62
Transferrin-targeted nanoparticles containing zoledronic acid as a potential to inhibit glioblastoma growth 62
Prognostic value of EGFR and EGFR-MEDIATED transduction signal inhibition: effective therapeutic strategies in the management of laryngeal cancer 62
A mechanistic study on the cardiotoxicity of 5-fluorouracil in vitro and clinical and occupational perspectives. 61
Silybin–Phosphatidylcholine Complex Protects Human Gastric and Liver Cells from Oxidative Stress 60
Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer? 60
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells 59
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion. 58
Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells 58
Advantages and risks of nanotechnologies in cancer patients and occupationally exposed workers. 57
Radiotherapy prolongs the survival of advanced non-smallcell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev) 57
Aggressiveness pattern and second primary tumor risk associated with basaloid squamous cell carcinoma of the larynx 56
Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures 56
Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms 55
Erlotinib: early clinical development in brain cancer. 55
Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid. 53
MicroRNA-125a-5p Is a Downstream Effector of Sorafenib in Its Antiproliferative Activity Toward Human Hepatocellular Carcinoma Cells 53
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 53
Bovine serum amine oxidase and spm potentiate docetaxel and interferon-alpha effects in inducing apoptosis on human cancer cells through the generation of oxidative stress. 52
Il recettore dell’ urotensina: un nuovo marker per il differenziamento ed il target nel cancro del colon? 52
Zoledronic acid encapsulated in self-assembly pegylated nanoparticles as a new delivery system against brain tumors 51
Emerging pathways as individualized therapeutic target of multiple myeloma. 51
Measurement of autophagy by flow cytometry 51
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. 50
UROTENSIN II RECEPTOR IS INVOLVED IN THE REGULATION OF MOTILITY OF PROSTATE ADENOCARCINOMA CELLS AND PREDICTS THE CLINICAL OUTCOME OF PROSTATE CANCER PATIENTS 50
A hydroquinone-based derivative elicits apoptosis and autophagy via activating a ros-dependent unfolded protein response in human glioblastoma 50
Optimizing treatment of metastatic colorectal cancer patients with anti-EGFR antibodies: overcoming the mechanisms of cancer cell resistance. 49
Drug-drug interactions based on pharmacogenetic profile between highly active antiretroviral therapy and antiblastic chemotherapy in cancer patients with HIV infection 49
Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells. 48
MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer 48
Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes. 47
Liposome armed with herpes virus-derived gH625 peptide to overcome doxorubicin resistance in lung adenocarcinoma cell lines 47
Interleukin 18: Friend or foe in cancer. 46
Urotensin-II receptor: a double identity receptor involved in vasoconstriction and in the development of digestive tract cancers and other tumors 46
Anti-inflammatory drugs as anticancer agents 46
New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study. 45
Zoledronic acid delivered by self-assembly pegylated nanoparticles has antitumor efficacy against glioblastoma cell lines and xenografts 45
Long non-coding RNAs as important biomarkers in laryngeal cancer and other head and neck tumours 45
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism. 43
Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses 43
Combined treatment with PPAR-γ agonists in pancreatic cancer: a glimmer of hope for cancer therapy? 42
Self-assembly nanoparticles for the delivery of bisphosphonates into tumors. 41
Levofolene modulates apoptosis induced by 5-fluorouracil through autophagy inhibition: Clinical and occupational implications 41
Ipilimumab for the treatment of metastatic prostate cancer 41
Testicular cancer from diagnosis to epigenetic factors 41
Peptide functionalization of silicon for detection and classification of prostatic cells 41
CYR61 DOWN-MODULATION SENSITIZES PROSTATE CANCER CELLS TO ZOLEDRONIC ACID AND DOCETAXEL: A NEW ANTICANCER STRATEGY 41
Insight toward the microRNA profiling of laryngeal cancers: Biological role and clinical impact 41
LncRNAs and Immunity: Coding the Immune System with Noncoding Oligonucleotides. 39
Chitosan-based polyelectrolyte complexes for doxorubicin and zoledronic acid combined therapy to overcome multidrug resistance 39
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 38
Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade 38
Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide 38
Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells. 37
The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells. 37
Urotensin-II-Targeted Liposomes as a New Drug Delivery System towards Prostate and Colon Cancer Cells 36
Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors 36
Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem 36
CYR61 down-modulation induced by zoledronic acid impairs cell motility and sensitizes prostate cancer cells to docetaxel: A new anti-cancer strategy 35
Nanotechnologies to use zoledronic acid as a potent antitumoral agent 35
Hepatocarcinoma: genetic and epigenetic features 34
Molecular and preclinical models enhancing anti-tumour activity of zoledronic acid 34
Autophagic cell death: A new frontier in cancer research 34
Non-coding RNAs as a new dawn in tumor diagnosis 33
In vitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsilon-caprolactone) block copolymers: Do nanocarrier properties have a role? 33
The role of micrornas in development of colitis-associated colorectal cancer 33
Long non-coding RNAs in cancer stem cells 33
Molecular markers as a new tool for diagnostic and prognostic definition of type 2 diabetes mellitus 32
Extracellular Vesicles: New Endogenous Shuttles for miRNAs in Cancer Diagnosis and Therapy? 32
Protein kinase a detection in human urine samples 31
The stress hormone norepinephrine increases migration of prostate cancer cells in vitro and in vivo 30
Stealth liposomes for the delivery of zoledronic acid into tumors enhance the anticancer activity of the drug 30
Prognostic role of translocator protein and oxidative stress markers in chronic lymphocytic leukemia patients treated with bendamustine plus rituximab. 27
Nanoparticles releasing zoledronic acid have antitumor activity against experimental models of human glioblastoma 27
ZOLEDRONIC ACID INCREASES THE EXPRESSION OF NDRG1 GENE IN HUMAN ANDROGEN-INDEPENDENT PROSTATE CANCER PC3 CELLS 26
Possible Effects of Uremic Toxins p-Cresol, Indoxyl Sulfate, p-Cresyl Sulfate on the Development and Progression of Colon Cancer in Patients with Chronic Renal Failure 26
Immunotherapy of colorectal cancer: New perspectives after a long path 25
MicroRNA-nanoparticles against cancer: Opportunities and challenges for personalized medicine 24
A Proteomic Approach Reveals That miR-423-5p Modulates Glucidic and Amino Acid Metabolism in Prostate Cancer Cells 22
Hybrid lipid self-assembling nanoparticles for brain delivery of microRNA. 21
Molecular Characterization of Cancer Associated Fibroblasts in Prostate Cancer 18
Metastatic colorectal cancer and type 2 diabetes: prognostic and genetic interactions 18
Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer 17
OVERVIEW OF FDA-APPROVED ANTI CANCER DRUGS USED FOR TARGETED THERAPY 17
Totale 4.735
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.943
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.943
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201916 0 0 0 0 0 0 0 0 0 0 8 8
2019/2020545 127 80 13 20 68 18 98 38 36 19 21 7
2020/2021667 38 8 56 32 101 27 84 50 51 67 83 70
2021/2022688 24 11 11 12 206 11 15 22 30 89 50 207
2022/20231.710 155 49 29 193 149 163 3 106 750 23 55 35
2023/2024547 72 32 54 37 202 93 19 20 12 5 1 0
Totale 4.838